Source: BIOSPACE

Onkaido: Moderna Therapeutics, Inc. Appoints Oncology Leader As President Of Onkaido Therapeutics

/www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup" ALT"free biotech news">/enewsletters.biospace.com/images/news/cta-latest-biotech-news.jpg" ALIGN"bottom" USEMAP"#cta-BiotechNews" border"0" alt"Get the latest biotech news where you want it. Sign up for the...

Read full article »
Onkaido's Competitors | Onkaido's News | Onkaido's Financials
Stay up-to-date with the latest news on Onkaido Therapeutics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

President

Steve Kelsey

CEO Approval Rating

73/100

Read more
Stay up-to-date with the latest news on Onkaido Therapeutics